chapter 18 cholinoceptor antagonists. part a muscarinic receptor antagonists
Post on 18-Jan-2018
242 Views
Preview:
DESCRIPTION
TRANSCRIPT
Chapter 18Chapter 18
Cholinoceptor AntagonistsCholinoceptor Antagonists
Part APart AMuscarinic receptor antagonistsMuscarinic receptor antagonists
OH
CH
NCH3
CH
CH3
CH3
CH O CH C6H5
CH2CH2
CH2
C
O
OH
CH
NCH3
CH
CH3
CH3
CH O CH C6H5
CH2CH
CH
C
O
O
OH
CH
NCH3
CH
CH3
CH3
CH O CH C6H5
CH2
CH
C
O
CH2
HO
Atropine Atropine 阿托品阿托品ScopolamineScopolamine东莨菪碱东莨菪碱
AnisodamineAnisodamine山莨菪碱山莨菪碱
Atropine-like alkaloidsAtropine-like alkaloids
A A Muscarinic receptor antagonistsMuscarinic receptor antagonists
1. 1. Pharmacological effectsPharmacological effects(1) Inhibition of exocrine gland secretion (1) Inhibition of exocrine gland secretion salivary, sweat glandssalivary, sweat glands tear, respiratory tract glandstear, respiratory tract glands relatively ineffective: GI tractrelatively ineffective: GI tract(2) Eye (2) Eye mydriasismydriasis rise in intraocular pressurerise in intraocular pressure paralysis of accommodationparalysis of accommodation
Atropine Atropine 阿托品阿托品
pilocarpinepilocarpine
atropineatropine
(3) Antispamodic action on smooth muscle (3) Antispamodic action on smooth muscle
sensitive:sensitive: GI, urinary bladder (spasmodic state) GI, urinary bladder (spasmodic state) relatively insensitive:relatively insensitive: bile duct, urinary tract, br bile duct, urinary tract, br
onchial tractonchial tract insensitive:insensitive: uterus uterus
(4) Heat (4) Heat HRHR↓:↓: because of M because of M11 blockade; blockade; HRHR↑:↑: if if vagal tone ↑ vagal tone ↑ A-V conduction:A-V conduction: if if vagal tone ↑vagal tone ↑
A A Muscarinic receptor antagonistsMuscarinic receptor antagonists
(5) Blood vessels and blood pressure(5) Blood vessels and blood pressure
Therapeutic doses:Therapeutic doses: no effect no effect Larger doses:Larger doses: vasodilatation vasodilatation in the skin (indirect) in the skin (indirect) and in septic shockand in septic shock (6) Central stimulation(6) Central stimulation
Larger dosesLarger doses
A A Muscarinic receptor antagonistsMuscarinic receptor antagonists
2. 2. Clinical usesClinical uses
(1) Spasms of smooth muscles(1) Spasms of smooth muscles GI, biliary or renal colic, enuresisGI, biliary or renal colic, enuresis
(2) Inhibiting exocrine gland secretion(2) Inhibiting exocrine gland secretion Preanesthetic medicationPreanesthetic medication
(3) Ophthalmology(3) Ophthalmology Acute iritis or iridocyclitis:Acute iritis or iridocyclitis: mydriatics/miotics mydriatics/miotics Measurement of the refraction:Measurement of the refraction: children children
A A Muscarinic receptor antagonistsMuscarinic receptor antagonists
(4) Bradyarrhythmia(4) Bradyarrhythmia sinus or nodal bradycardia, A-V blocksinus or nodal bradycardia, A-V block
(5) Septic shock(5) Septic shock
(6) Antidote for organophosphate poisoning(6) Antidote for organophosphate poisoning
A A Muscarinic receptor antagonistsMuscarinic receptor antagonists
3. 3. Adverse effectsAdverse effects
(1) Side effects(1) Side effects
(2) Central toxicity(2) Central toxicity Lethal dose: 80~130 mg (adults), 10 mg (child)Lethal dose: 80~130 mg (adults), 10 mg (child)
A A Muscarinic receptor antagonistsMuscarinic receptor antagonists
(3) Detoxication (3) Detoxication Symptomatic treatment: diazepam, Symptomatic treatment: diazepam, etcetc.. Physostigmine (Physostigmine ( 毒扁豆碱毒扁豆碱 ) or pilocarpine () or pilocarpine ( 毛果毛果芸香碱芸香碱 ))
(4) Contraindications(4) Contraindications glaucoma, prostatauxe, feverglaucoma, prostatauxe, fever
A A Muscarinic receptor antagonistsMuscarinic receptor antagonists
Actions and clinical usesActions and clinical uses
Peripheral effects are similar to atropine; Peripheral effects are similar to atropine; but has stronger central effects (depression)but has stronger central effects (depression)
Pre-anesthetic medication, prevention of Pre-anesthetic medication, prevention of motion sickness, Parkinson’s disease motion sickness, Parkinson’s disease
Scopolamine Scopolamine 东莨菪碱东莨菪碱A A Muscarinic receptor antagonistsMuscarinic receptor antagonists
Actions and clinical usesActions and clinical uses
Primarily acts on the smooth muscles of Primarily acts on the smooth muscles of peripheral organs; weak in CNS, glands, peripheral organs; weak in CNS, glands, eyeeye
Septic shock, spasms of smooth muscles Septic shock, spasms of smooth muscles of GI and biliary ductof GI and biliary duct
Anisodamine Anisodamine 山莨菪碱山莨菪碱 , 654-2, 654-2
A A Muscarinic receptor antagonistsMuscarinic receptor antagonists
Synthetic mydriaticsSynthetic mydriatics
Homatropine Homatropine 后马托品后马托品shorter duration (1~2 days)shorter duration (1~2 days)Examination of eyes generallyExamination of eyes generally
TropicamideTropicamide 托吡卡胺托吡卡胺 ( ( 1/4 day1/4 day ))
Synthetic Substitutes for atropineSynthetic Substitutes for atropine
A A Muscarinic receptor antagonistsMuscarinic receptor antagonists
Propantheline bromide Propantheline bromide 丙胺太林 丙胺太林 (( 普鲁本辛普鲁本辛 )) poor absorption (po) and BBB penetrationpoor absorption (po) and BBB penetration antispasmodic effects in GI, treatment of peptic ulcer antispasmodic effects in GI, treatment of peptic ulcer
diseasedisease
Benactyzine Benactyzine 贝那替秦 贝那替秦 (( 胃复康胃复康 )) peptic ulcer disease with anxiety, GI and urinary blapeptic ulcer disease with anxiety, GI and urinary bla
dder spasmsdder spasms
Synthetic AntispasmadicsSynthetic Antispasmadics
A A Muscarinic receptor antagonistsMuscarinic receptor antagonists
Pirenzepine Pirenzepine 哌仑西平哌仑西平 inhibition of gastric acid and pepsin secretinhibition of gastric acid and pepsin secret
ionion
weak in salivary glands and eye, poor penweak in salivary glands and eye, poor penetration into CNSetration into CNS
used in treatment of peptic ulcer diseaseused in treatment of peptic ulcer disease
MM1 1 receptor antagonistsreceptor antagonists
A A Muscarinic receptor antagonistsMuscarinic receptor antagonists
Part BPart B Nicotinic receptor antagonistsNicotinic receptor antagonists
Acting on sympathetic and parasympatheActing on sympathetic and parasympathetic ganglionic cells; reducing blood presstic ganglionic cells; reducing blood pressure by inhibiting sympathetic gangliaure by inhibiting sympathetic ganglia
Short-acting; tachyphylaxisShort-acting; tachyphylaxis
Used for controlled hypotensionUsed for controlled hypotension
B B Nicotinic receptor antagonistsNicotinic receptor antagonists
1. 1. Depolarizing neuromuscular blockersDepolarizing neuromuscular blockers (depolarizing skeletal muscle relaxants)(depolarizing skeletal muscle relaxants)
Binding to NBinding to NN N receptors, initial excitation action, then receptors, initial excitation action, then persisting depolarization and resistance to AChpersisting depolarization and resistance to ACh
initially transient fasciculationsinitially transient fasciculations tachyphylaxis after repeated usestachyphylaxis after repeated uses anti-AChE potentiates their effectsanti-AChE potentiates their effects no ganglion-blocking effects at therapeutic dosesno ganglion-blocking effects at therapeutic doses
B B Nicotinic receptor antagonistsNicotinic receptor antagonists
Succinylcholine Succinylcholine 琥珀胆碱琥珀胆碱 , , ScolineScoline
NCH2CH2OCCH2CH2COCH2CH2NH3C
CH3
O
++
H3C
H3C
CH3
CH3
O
B B Nicotinic receptor antagonistsNicotinic receptor antagonists
1.1 1.1 Pharmacological effectsPharmacological effects
Transient excitation (fasciculations), and theTransient excitation (fasciculations), and then inhibition (relaxation)n inhibition (relaxation)
neck, limbs > face, tongue, throat; less effectivneck, limbs > face, tongue, throat; less effective on breath muscles at therapeutic dosese on breath muscles at therapeutic doses
Short-acting (5 min), degradation by Short-acting (5 min), degradation by plasma plasma pseudocholinesterasespseudocholinesterases
B B Nicotinic receptor antagonistsNicotinic receptor antagonists
1.2 1.2 Clinical usesClinical uses
An adjuvant in anesthesia or operationAn adjuvant in anesthesia or operation Intubation of Intubation of trachea, esophagus, trachea, esophagus, ect.ect. Prevention of trauma during electroshock theraPrevention of trauma during electroshock thera
pypy
Contraindicated in awake patients, should Contraindicated in awake patients, should use under anesthesiause under anesthesia
B B Nicotinic receptor antagonistsNicotinic receptor antagonists
1.3 1.3 Adverse effectsAdverse effects
(1)Apnea (respiratory paralysis)(1)Apnea (respiratory paralysis) overdose or hypersensitive patients;overdose or hypersensitive patients; neostigmine potentiates the toxic effectsneostigmine potentiates the toxic effects
(2) Muscle spasm (2) Muscle spasm muscular pain after operationmuscular pain after operation
B B Nicotinic receptor antagonistsNicotinic receptor antagonists
(3) Elevation of K(3) Elevation of K++ in plasma in plasma contraindicated in patients with a tendency of contraindicated in patients with a tendency of
hyperkalemia hyperkalemia
(4) Malignant hyperthermia(4) Malignant hyperthermia genetic abnormalitygenetic abnormality
(5) Others(5) Others rise in intraocular pressure (glaucoma);rise in intraocular pressure (glaucoma); histamine release; histamine release;
B B Nicotinic receptor antagonistsNicotinic receptor antagonists
1.4 1.4 Drug interactionsDrug interactions
ThiopentalThiopental
ChE inhibitors: ChE inhibitors: AChE inhibitors, cyclophosphamide, procaAChE inhibitors, cyclophosphamide, proca
ine, ine, etcetc..
Some antibiotics:Some antibiotics: kanamycin, polimyxins, kanamycin, polimyxins, etc.etc. (synergism in n (synergism in n
euromuscular blocking) euromuscular blocking)
B B Nicotinic receptor antagonistsNicotinic receptor antagonists
2. 2. Nondepolarizing neuromuscular blockersNondepolarizing neuromuscular blockers(nondepolarizing skeletal muscle relaxants)(nondepolarizing skeletal muscle relaxants)
2.1 Effects: 2.1 Effects: competitive blockade of competitive blockade of NNN N
receptorsreceptors2.2 Uses: 2.2 Uses: adjuvant treatment of anesthesia oadjuvant treatment of anesthesia o
r operationsr operations
Tubocurarine Tubocurarine 筒箭毒碱筒箭毒碱
B B Nicotinic receptor antagonistsNicotinic receptor antagonists
2.3 Adverse effects2.3 Adverse effects
Respiratory paralysis: Respiratory paralysis: can be reversed by neostigmcan be reversed by neostigmineine
Enhancing histamine release: Enhancing histamine release: BP BP , hypotension, b, hypotension, bronchoconstriction, salivery secretionronchoconstriction, salivery secretion
Blocking ganglion: Blocking ganglion: BP BP
Contraindications: Contraindications: myasthenia gravis, bronchial astmyasthenia gravis, bronchial asthma, shock, child (< 10 y)hma, shock, child (< 10 y)
B B Nicotinic receptor antagonistsNicotinic receptor antagonists
Benzylisoquinolines Benzylisoquinolines (苄基异喹啉类)(苄基异喹啉类) atracurium atracurium 阿曲库铵阿曲库铵 ; doxacurium ; doxacurium 多库铵多库铵 mivacurium mivacurium 米库铵米库铵Ammonio steroidsAmmonio steroids (类固醇铵类)(类固醇铵类) pancuronium pancuronium 泮库铵泮库铵 ;; vecuronium vecuronium 维库铵维库铵 ; ; pipecuronium pipecuronium 哌库铵哌库铵 ; rocuronium ; rocuronium 罗库铵罗库铵
Other nondepolarizing neuromOther nondepolarizing neuromuscular blockersuscular blockers
B B Nicotinic receptor antagonistsNicotinic receptor antagonists
top related